Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express05-11

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”) issued a notification on 11 May 2026 confirming that the English and Chinese versions of the following documents are now available online:

• Circular for the 2026 Annual General Meeting (AGM) and the 2026 Second H-Shareholders Class Meeting • Notice of the AGM • Notice of the 2026 Second H-Shareholders Class Meeting • Forms of Proxy

The materials can be accessed via the company’s website (www.fosunpharma.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).

Key operational arrangements:

1. Distribution format • Fosun Pharma encourages shareholders to use the web-based versions of all current and future corporate communications. • Shareholders who have previously elected to receive printed copies will find the current documents enclosed.

2. Change of communication preference • Shareholders encountering difficulties with email notifications or online access, or those wishing to switch to printed copies, should complete and return the enclosed Reply Form to Tricor Investor Services Limited, the H-share registrar, by post (prepaid label provided) or email (is-ecom@vistra.com). Printed copies will be sent free of charge upon request.

3. Provision of email addresses • Registered shareholders are responsible for supplying a valid email address. Without a functioning address, the company will continue to send printed notices and actionable corporate communications until updated details are provided.

4. Enquiry hotline • Questions can be directed to Tricor Investor Services Limited at (852) 2980 1333, Monday to Friday, 9:00 a.m. – 6:00 p.m. (excluding public holidays).

The notification is issued by order of the board and signed by Chairman Chen Yuqing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment